Here are four quick facts:
1. JPMorgan Chase analysts have a $15.52 price objective on the stock, suggesting a possible downside of 4.64 percent from the stock’s current price.
2. Smith & Nephew has a 12-month low of $14.40.
3. The 12-month high is $17.41.
4. The company has a market cap of $150 million.
More articles on devices:
7 new device launches & releases — January 26, 2015
VertiFlex raises $26.8M in funds: 3 points
Wells Fargo: LDR stock receives “market perform” rating — 4 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
